戻る
Hua Medicine (Shanghai) Ltd. (02552.HK)価格
02552.HK 株価推移チャート
HUA MEDICINE-B (02552.HK)
Hua Medicine (Shanghai) Ltd.
HK$3.25
-4.69%
$-0.16
休場: Jan 16, 16:00:00 HKT
データなしFollow-Up Questions
Hua Medicine (Shanghai) Ltd.の主要な財務諸表は何ですか？
02552.HKの主要な財務比率は何ですか？
Hua Medicine (Shanghai) Ltd.の収益はセグメントまたは地域別にどのように分けられていますか？
Hua Medicine (Shanghai) Ltd.は収益を上げていますか？
Hua Medicine (Shanghai) Ltd.に負債はありますか？
Hua Medicine (Shanghai) Ltd.の発行済株式数は何株ですか？
主要データ
前終値
$3.41
始値
$3.41
当日レンジ
$3.2 - $3.41
52週レンジ
$1.24 - $4.95
取引高
5.3M
平均取引高
3.5M
1株当たり利益(TTM)
1.21
配当利回り
--
時価総額
$3.2B
HUA MEDICINE-Bとは何ですか？
Hua Medicine Ltd. provides drug discovery and development services. The company is headquartered in Shanghai, Shanghai and currently employs 285 full-time employees. The company went IPO on 2018-09-14. The firm is also engaged in the commercialization of HuaTangNing products. The Company’s main product pipeline dorzagliatin or HMS5552 is a glucokinase activator or GKA, designed to control the progressive degenerative nature of diabetes by restoring glucose homeostasis in Type 2 diabetes. The firm mainly conducts its business in the domestic market.